Earnings Outlook For Vaxcyte
Benzinga Insights 8 months ago
Earnings
Vaxcyte (NASDAQ:PCVX) is preparing to release its quarterly earnings on Tuesday, 2026-02-24. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Vaxcyte to report an earnings per share (EPS) of $-1.49.
Anticipation surrounds Vaxcyte's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Performance in Previous Earnings
Last quarter the company missed EPS by $0.31, which was followed by a 2.49% drop in the share price the next day.
Here's a look at Vaxcyte's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -1.25 | -1.15 | -0.92 | -1.14 |
| EPS Actual | -1.56 | -1.22 | -1.04 | -1.02 |
| Price Change % | -2.00 | -9.00 | 8.00 | -1.00 |
Tracking Vaxcyte's Stock Performance
Shares of Vaxcyte were trading at $58.51 as of February 20. Over the last 52-week period, shares are down 24.76%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Vaxcyte visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.